NuVasive
-
Spine
Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting
AUDUBON, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, presented five-year…
Read More » -
Spine
Globus Medical and NuVasive to Sponsor and Participate at EUROSPINE 2023
AUDUBON, Pa., Sept. 27, 2023 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced…
Read More » -
Spine
NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting
SAN DIEGO, Aug. 30, 2023 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Financial
NuVasive Announces Conference Call and Webcast of Second Quarter 2023 Results
SAN DIEGO, July 24, 2023 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Financial
NuVasive Announces First Quarter 2023 Financial Results
–Continued above-market worldwide net sales growth of 5.8% as reported and 7.7% on a constant currency basis––U.S. cervical delivers sixth…
Read More » -
Regulatory
NuVasive Specialized Orthopedics Expands Indications of Precice Limb Lengthening System to Treat Pediatric Patients
SAN DIEGO, March 20, 2023 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Spine
NuVasive to Participate in Upcoming Spine Society Annual Conferences
SAN DIEGO, March 14, 2023 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Financial
NuVasive to Participate in Upcoming Investor Conferences
SAN DIEGO, Feb. 27, 2023 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…
Read More » -
Financial
NuVasive Announces Fourth Quarter and Full-Year 2022 Financial Results and 2023 Net Sales Guidance
– Full-year 2022 net sales grew 5.5% as reported, 8.5% on a constant currency basis – – Continued strong international growth in 2022 –…
Read More » -
Spine
NuVasive Enhances C360 Portfolio with Expanded Indications for Modulus Cervical and Attrax Putty
Attrax Putty is now on-label for use with cervical Modulus interbody implants SAN DIEGO, Feb. 21, 2023 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the…
Read More » -
Financial
Globus Medical and NuVasive to Combine in All-Stock Transaction to Create Innovative Global Musculoskeletal Company Focused on Patient Care
Capitalizes on complementary global commercial organizations and accelerates Globus Medical’s and NuVasive’s globalization strategies to increase customer reach and deepen…
Read More »